EDN3
Basic information
Region (hg38): 20:59300443-59325992
Links
Phenotypes
GenCC
Source:
- Waardenburg syndrome type 4B (Strong), mode of inheritance: AD
- Waardenburg syndrome type 4B (Strong), mode of inheritance: AR
- Waardenburg syndrome type 4B (Moderate), mode of inheritance: Semidominant
- Hirschsprung disease, susceptibility to, 4 (Moderate), mode of inheritance: AD
- Waardenburg-Shah syndrome (Supportive), mode of inheritance: AD
- Hirschsprung disease, susceptibility to, 4 (Limited), mode of inheritance: Unknown
- Waardenburg syndrome type 4B (Limited), mode of inheritance: AD
- Waardenburg syndrome type 4B (Limited), mode of inheritance: AD
- Waardenburg syndrome type 4B (Moderate), mode of inheritance: AR
- Waardenburg syndrome type 4B (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Waardenburg syndrome, type 4B; Central hypoventilation syndrome, congenital; Hirschsprung disease, susceptibility to, 4 | AD/AR | Audiologic/Otolaryngologic; Gastrointestinal; Neurologic; Pulmonary | Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; In conditions that may involve Hirschsprung disease, recognition of potential GI anomalies (eg, aganglionosis) may allow prompt recognition and treatment; In Central hypoventilation syndrome, congenital, early recognition and interventions to support ventilation (as well as avoidance of exacerbating factors) can reduce morbidity and mortality | Audiologic/Otolaryngologic; Dermatologic; Gastrointestinal; Neurologic; Ophthalmologic; Pulmonary | 8696331; 8630502; 8630503; 9279758; 9359047; 10231870; 11303518; 19764030; 20009762 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EDN3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | 19 | ||||
missense | 40 | 44 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 1 | 3 | |||
non coding | 40 | 19 | 13 | 72 | ||
Total | 0 | 2 | 85 | 39 | 14 |
Variants in EDN3
This is a list of pathogenic ClinVar variants found in the EDN3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-59300454-T-A | Hirschsprung Disease, Dominant | Uncertain significance (Jun 14, 2016) | ||
20-59300545-G-C | Hirschsprung Disease, Dominant | Uncertain significance (Jun 14, 2016) | ||
20-59300565-G-A | Hirschsprung Disease, Dominant • not specified | Benign/Likely benign (Jul 01, 2024) | ||
20-59300649-G-A | Hirschsprung disease, susceptibility to, 4 | Uncertain significance (Jan 12, 2018) | ||
20-59300693-C-T | Hirschsprung disease, susceptibility to, 4 | Uncertain significance (Jan 13, 2018) | ||
20-59300698-G-A | Hirschsprung disease, susceptibility to, 4 | Uncertain significance (Jan 12, 2018) | ||
20-59300727-G-A | Hirschsprung disease, susceptibility to, 4 | Uncertain significance (Jan 13, 2018) | ||
20-59300728-G-A | Hirschsprung disease, susceptibility to, 4 | Uncertain significance (Jan 13, 2018) | ||
20-59300736-T-A | Hirschsprung disease, susceptibility to, 4 | Benign (Jan 13, 2018) | ||
20-59300769-C-T | Hirschsprung disease, susceptibility to, 4 | Likely benign (Jan 12, 2018) | ||
20-59300794-C-A | Uncertain significance (Sep 08, 2021) | |||
20-59300823-G-C | Uncertain significance (Aug 04, 2023) | |||
20-59300836-T-G | not specified | Likely benign (Sep 06, 2017) | ||
20-59300838-T-A | Inborn genetic diseases | Uncertain significance (May 17, 2023) | ||
20-59300855-T-G | Hirschsprung disease, susceptibility to, 4 • Hirschsprung disease, susceptibility to, 4;Waardenburg syndrome type 4B | Uncertain significance (Feb 15, 2022) | ||
20-59300860-C-T | Likely benign (Aug 16, 2022) | |||
20-59300861-G-A | Hirschsprung disease, susceptibility to, 4 • not specified | Conflicting classifications of pathogenicity (Feb 01, 2024) | ||
20-59300871-G-T | Likely benign (Sep 14, 2021) | |||
20-59300989-C-T | Benign (Dec 17, 2018) | |||
20-59301100-G-A | Benign (Nov 11, 2018) | |||
20-59301185-G-T | Benign (Nov 11, 2018) | |||
20-59301494-G-A | Uncertain significance (Mar 02, 2023) | |||
20-59301498-AGAGACTGTGGCTGGCCCTGGCGAG-A | EDN3-related disorder | Likely benign (Nov 24, 2023) | ||
20-59301498-A-AGAGACTGTGGCTGGCCCTGGCGAG | Abnormal rectum morphology;Megacolon • EDN3-related disorder | Uncertain significance (Oct 08, 2022) | ||
20-59301501-G-C | Uncertain significance (Jan 24, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EDN3 | protein_coding | protein_coding | ENST00000337938 | 5 | 25566 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0246 | 0.922 | 125666 | 0 | 5 | 125671 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.939 | 168 | 137 | 1.23 | 0.00000874 | 1519 |
Missense in Polyphen | 33 | 34.757 | 0.94946 | 366 | ||
Synonymous | 0.118 | 57 | 58.1 | 0.980 | 0.00000390 | 492 |
Loss of Function | 1.65 | 4 | 9.50 | 0.421 | 4.99e-7 | 107 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000123 | 0.000123 |
Ashkenazi Jewish | 0.000101 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.00000895 | 0.00000880 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Endothelins are endothelium-derived vasoconstrictor peptides.;
- Disease
- DISEASE: Congenital central hypoventilation syndrome (CCHS) [MIM:209880]: Rare disorder characterized by abnormal control of respiration in the absence of neuromuscular or lung disease, or an identifiable brain stem lesion. A deficiency in autonomic control of respiration results in inadequate or negligible ventilatory and arousal responses to hypercapnia and hypoxemia. {ECO:0000269|PubMed:8696331}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Waardenburg syndrome 4B (WS4B) [MIM:613265]: A disorder characterized by the association of Waardenburg features (depigmentation and deafness) with the absence of enteric ganglia in the distal part of the intestine (Hirschsprung disease). {ECO:0000269|PubMed:11303518, ECO:0000269|PubMed:12189494, ECO:0000269|PubMed:8630503}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Signaling by GPCR;Signal Transduction;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;GPCR signaling-G alpha i;G alpha (q) signalling events;GPCR downstream signalling;Endothelins
(Consensus)
Recessive Scores
- pRec
- 0.370
Intolerance Scores
- loftool
- 0.0739
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 28.93
Haploinsufficiency Scores
- pHI
- 0.372
- hipred
- N
- hipred_score
- 0.450
- ghis
- 0.443
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0610
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Edn3
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); embryo phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); pigmentation phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- edn3b
- Affected structure
- melanocyte
- Phenotype tag
- abnormal
- Phenotype quality
- decreased pigmentation
Gene ontology
- Biological process
- neural crest cell migration;positive regulation of leukocyte chemotaxis;regulation of systemic arterial blood pressure by endothelin;cellular calcium ion homeostasis;signal transduction;cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;cell-cell signaling;multicellular organism development;blood circulation;positive regulation of cell population proliferation;positive regulation of heart rate;regulation of gene expression;regulation of signaling receptor activity;cellular magnesium ion homeostasis;artery smooth muscle contraction;vein smooth muscle contraction;regulation of vasoconstriction;peptide hormone secretion;neuron differentiation;melanocyte differentiation;neutrophil chemotaxis;vasoconstriction;positive regulation of MAP kinase activity;positive regulation of cell differentiation;positive regulation of mitotic nuclear division;positive regulation of hormone secretion;inositol phosphate-mediated signaling;regulation of developmental pigmentation;positive regulation of potassium ion transmembrane transport
- Cellular component
- extracellular region;extracellular space;cell
- Molecular function
- signaling receptor binding;hormone activity;endothelin B receptor binding